French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
데이터 추가 비고
조치
The batch 737645601 of the reagent denominated HEMOLINE PERFORMANCE DIPHASIQUE * ref 52510 of the company BIOMERIEUX is withdrawn from the market because of a risk of microbial contamination of certain vials of blood cultures.